BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29331185)

  • 1. [Patients and caregivers in the treatment of addictions].
    Coppel A
    Rev Infirm; 2018 Jan; 67(237):16-18. PubMed ID: 29331185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Addictology, promoting users' power to act].
    Morel A
    Rev Infirm; 2018 Jan; 67(237):19-21. PubMed ID: 29331186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nursing role and risk reduction for drug users].
    Denize Y; Humbert S; Laborde A; Kreiss A; Waeckerlé G
    Rev Infirm; 2018 Jan; 67(237):22-24. PubMed ID: 29331187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The coaching, a posture of the caregiver in addictology].
    Mertel LC; Thorens G
    Soins Psychiatr; 2020; 41(326):16-19. PubMed ID: 32718521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Day clinic, a gateway towards risk reduction].
    Ben Nifla V; Celli P; Samba H; Vincent C
    Rev Infirm; 2018 Jan; 67(237):28-30. PubMed ID: 29331189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The place of the psychologist in an addiction care].
    Goujat R
    Soins Psychiatr; 2020; 41(326):20-23. PubMed ID: 32718522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Not Available].
    Papas A
    Rev Infirm; 2018 Jan; 67(237):15. PubMed ID: 29331184
    [No Abstract]   [Full Text] [Related]  

  • 8. [The community as a place of intervention in the treatment of addictions].
    Penzenstadler L; Zullino D; Thorens G
    Rev Med Suisse; 2019 Sep; 15(663):1668-1670. PubMed ID: 31532118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining the ethical boundaries of harm reduction: from addictions to general psychiatry.
    Lev-Ran S; Nitzan U; Fennig S
    Isr J Psychiatry Relat Sci; 2014; 51(3):175-80. PubMed ID: 25618280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In support of abstinence. Harm reduction ultimately fails to improve the quality of life for people with addictions.
    Tieman D
    Behav Healthc; 2007 Jul; 27(7):45. PubMed ID: 18027622
    [No Abstract]   [Full Text] [Related]  

  • 11. Contingencies of the will: Uses of harm reduction and the disease model of addiction among health care practitioners.
    Szott K
    Health (London); 2015 Sep; 19(5):507-22. PubMed ID: 25394654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual pathway of professional attitude among health care workers serving HIV/AIDS patients and drug users.
    Shen YM; Lin SR; Chen CL; Huang TM; Huang YH; See LC; Deng FL
    AIDS Care; 2013; 25(3):309-16. PubMed ID: 22783908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addiction: Not a Hangnail, But Not Poverty Either.
    Levounis P
    Acad Psychiatry; 2018 Apr; 42(2):277-278. PubMed ID: 29549609
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
    Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
    Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Training the next generation of providers in addiction medicine.
    Rasyidi E; Wilkins JN; Danovitch I
    Psychiatr Clin North Am; 2012 Jun; 35(2):461-80. PubMed ID: 22640766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Similarities and Differences Between Harm-Reduction and Substitute Addiction-- Implications for the Health Professions.
    Sussman S; Sinclair DL; Clifasefi SL; Collins SE
    Eval Health Prof; 2024 Mar; 47(1):75-80. PubMed ID: 38247290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substance use disorders and addictions among carers].
    Menecier P
    Soins; 2020 Jun; 65(846):10-13. PubMed ID: 33012409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BehavioR: a digital platform for prevention and management of behavioural addictions.
    Balhara YPS; Anwar N
    WHO South East Asia J Public Health; 2019 Sep; 8(2):101-103. PubMed ID: 31441445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New indications for existing drugs; repurposing in psychiatry and addiction medicine].
    Strous JFM; van den Brink W
    Ned Tijdschr Geneeskd; 2018 May; 162():. PubMed ID: 30020573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.